Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2025-12-25 @ 9:53 PM
NCT ID:
NCT01660451
Group ID:
EG000
Title:
Part A: Indolent NHL/CLL
Description:
Participants with indolent Non-Hodgkin's lymphoma/Chronic lymphocytic leukemia \[iNHL/CLL\] received copanlisib 0.8 milligram per kilogram (mg/kg), maximum 65 mg, intravenous (IV) infusion dosing over 1 hour in 100 milliliter (mL) normal saline solution on Days 1, 8, and 15 of a 28-day treatment cycle until occurrence of progressive disease, as defined in the Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas by Cheson et al. 1999, clinical progression, unacceptable toxicity, or any other criteria meeting withdrawal from study.
Deaths Number Affected:
21
Deaths Number At Risk:
None
Serious Number Affected:
16
Serious Number At Risk:
33
Other Number Affected:
33
Other Number At Risk:
33
Study:
NCT01660451
Results Section:
NCT01660451
Adverse Events Module:
NCT01660451